AAME
Atlantic American Corporation
There isn't enough reported data to score AAME yet.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
AAME Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
AAME's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AAME.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
AAME PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.3x | $1.19 | — |
| Cheap | 5.4x | $1.51 | +27% |
| Fair | 14x | $3.87 | +225% |
| Expensive | 34x | $9.41 | +690% |
Historical ranges are pointers, not guarantees.
AAME's PE is 4.3x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
AAME Forward outlook
There aren't enough analyst estimates for AAME to show an outlook.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
AAME Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.28 | +$0.51 |
| Q3 2025 | $0.21 | +$0.56 |
| Q2 2025 | $0.09 | +$0.26 |
| Q1 2025 | -$0.10 | -$0.05 |
| Q4 2024 | -$0.23 | -$0.20 |
| Q3 2024 | -$0.35 | -350% |
| Q2 2024 | -$0.17 | -950% |
| Q1 2024 | -$0.05 | +$0.10 |
AAME has the stronger earnings trend. Trailing diluted EPS is up 22% for AAME versus IREN down 347%.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
AAME Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $51.3M | +4.5% |
| Q3 2025 | $53.8M | +21% |
| Q2 2025 | $55.3M | +16% |
| Q1 2025 | $50.1M | +6.7% |
| Q4 2024 | $49M | +4.9% |
| Q3 2024 | $44.5M | -0.2% |
| Q2 2024 | $47.7M | -3.1% |
| Q1 2024 | $47M | +1.6% |
AAME has the stronger quarterly revenue trend. Revenue is up 4.5% for AAME versus down 5.1% for IREN.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 3.3% | +2.2 points |
| Q3 2025 | 1.4% | +6.9 points |
| Q2 2025 | 7.6% | +9.4 points |
| Q1 2025 | 2.1% | +7.4 points |
| Q4 2024 | 1.1% | +7.8 points |
| Q3 2024 | -5.5% | -10 points |
| Q2 2024 | -1.8% | -6.3 points |
| Q1 2024 | -5.3% | -1.4 points |
AAME's operating margin was 3.3% last quarter, up 2.2 points from the same quarter a year ago.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
AAME Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $17.7M | +86% |
| Q3 2025 | $6.6M | +11298% |
| Q2 2025 | $9.1M | +2423% |
| Q1 2025 | -$986K | +$4.4M |
| Q4 2024 | $9.5M | +54% |
| Q3 2024 | $58K | -96% |
| Q2 2024 | $361K | -95% |
| Q1 2024 | -$5.4M | +$6.3M |
AAME has the stronger cash trend. Its trailing FCF is up 504% versus its history, compared with IREN at down 479%.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
AAME Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1K shares |
| 1 year | 0% | -2K shares |
| 3 years | 0% | +8K shares |
| 5 years | -6.5% | -1.4M shares |
| Available history | -5.3% | -1.1M shares |
AAME has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | $22,000 |
| Q1 2019 | $49,000 |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
AAME Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2025 | -4.7x | Net Cash |
| Q3 2025 | -4.4x | Net Cash |
| Q2 2025 | -11.6x | Net Cash |
| Q4 2023 | -290.6x | Net Cash |
| Q3 2023 | -4.5x | Net Cash |
| Q2 2023 | -13.3x | Net Cash |
| Q4 2022 | -9.0x | Net Cash |
| Q3 2022 | -4.1x | Net Cash |
AAME has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
AAME Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.3 | Neutral |
| Stochastic | 16.6 | Oversold |
AAME's weekly RSI is 37 (neutral) and its Stochastic is 17 (oversold).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
AAME PE vs Financial Services Sector
| Metric | AAME | Sector median | Relative |
|---|---|---|---|
| PE | 4.3x | 13x | 67% below |
| PE % | 5 | 63 | 58 pts below |
AAME is trading at 4.3x earnings, a 67% discount to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
AAME Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.18 | 0.8% above |
| 20 week MA | $1.36 | 13% below |
| 50 week MA | $2.04 | 42% below |
| 100 week MA | $2.08 | 43% below |
| 200 week MA | $2.05 | 42% below |
AAME has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 42% below its 200-week average.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
AAME Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.85 | $2.08 | +12% |
| 2021 | $2.08 | $3.21 | +54% |
| 2022 | $3.21 | $2.42 | -25% |
| 2023 | $2.42 | $2.45 | +1.2% |
| 2024 | $2.45 | $1.48 | -40% |
| 2025 | $1.48 | $2.55 | +72% |
| 2026 YTD | $2.55 | $1.19 | -53% |
AAME is down 53% so far in 2026, after finishing higher in four of the previous six years.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN has the edge over AAME on returns for 2026, with the stronger performance.